Literature DB >> 9710631

Intramolecular regulation of MyoD activation domain conformation and function.

J Huang1, H Weintraub, L Kedes.   

Abstract

The MyoD family of basic helix-loop-helix (bHLH) proteins is required for myogenic determination and differentiation. The basic region carries the myogenic code and DNA binding specificity, while the N terminus contains a potent transcriptional activation domain. Myogenic activation is abolished when the basic region, bound to a myogenic E box, carries a mutation of Ala-114. It has been proposed that DNA binding of the MyoD basic region leads to recruitment of a recognition factor that unmasks the activation domain. Here we demonstrate that an A114N mutant exhibits an altered conformation in the basic region and that this local conformational difference can lead to a more global change affecting the conformation of the activation domain. This suggests that the deleterious effects of this class of mutations may result directly from defective conformation. Thus, the activation domain is unmasked only upon DNA binding by the correct basic region. Such a coupled conformational relationship may have evolved to restrict myogenic specificity to a small number of bHLH proteins among many with diverse functions yet with DNA binding specificities known to be similar.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710631      PMCID: PMC109132          DOI: 10.1128/MCB.18.9.5478

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.

Authors:  A Voronova; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation.

Authors:  R L Davis; P F Cheng; A B Lassar; H Weintraub
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

3.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

4.  Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins.

Authors:  P J Godowski; D Picard; K R Yamamoto
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

5.  A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor.

Authors:  D Picard; S J Salser; K R Yamamoto
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

6.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

7.  Expression of a single transfected cDNA converts fibroblasts to myoblasts.

Authors:  R L Davis; H Weintraub; A B Lassar
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

8.  A colony bank containing synthetic Col El hybrid plasmids representative of the entire E. coli genome.

Authors:  L Clarke; J Carbon
Journal:  Cell       Date:  1976-09       Impact factor: 41.582

9.  The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain.

Authors:  N Mermod; E A O'Neill; T J Kelly; R Tjian
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

10.  Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2.

Authors:  B L Black; J D Molkentin; E N Olson
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

View more
  11 in total

1.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Determinants of myogenic specificity within MyoD are required for noncanonical E box binding.

Authors:  Analeah B Heidt; Anabel Rojas; Ian S Harris; Brian L Black
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

3.  Target identification using drug affinity responsive target stability (DARTS).

Authors:  Brett Lomenick; Rui Hao; Nao Jonai; Randall M Chin; Mariam Aghajan; Sarah Warburton; Jianing Wang; Raymond P Wu; Fernando Gomez; Joseph A Loo; James A Wohlschlegel; Thomas M Vondriska; Jerry Pelletier; Harvey R Herschman; Jon Clardy; Catherine F Clarke; Jing Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

4.  Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription.

Authors:  C Poizat; V Sartorelli; G Chung; R A Kloner; L Kedes
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 5.  Structure and functions of powerful transactivators: VP16, MyoD and FoxA.

Authors:  Hiroyuki Hirai; Tetsuya Tani; Nobuaki Kikyo
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

6.  Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD.

Authors:  Hugo C Olguín; Natalie E Patzlaff; Bradley B Olwin
Journal:  J Cell Biochem       Date:  2011-05       Impact factor: 4.429

7.  Specificity of Atonal and Scute bHLH factors: analysis of cognate E box binding sites and the influence of Senseless.

Authors:  Lynn M Powell; Aimée M Deaton; Martin A Wear; Andrew P Jarman
Journal:  Genes Cells       Date:  2008-08-04       Impact factor: 1.891

8.  Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcription.

Authors:  Paola Pellanda; Mattia Dalsass; Marco Filipuzzi; Alessia Loffreda; Alessandro Verrecchia; Virginia Castillo Cano; Hugo Thabussot; Mirko Doni; Marco J Morelli; Laura Soucek; Theresia Kress; Davide Mazza; Marina Mapelli; Marie-Eve Beaulieu; Bruno Amati; Arianna Sabò
Journal:  EMBO J       Date:  2021-04-01       Impact factor: 11.598

Review 9.  Reprogramming cells with synthetic proteins.

Authors:  Xiaoxiao Yang; Vikas Malik; Ralf Jauch
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

10.  MyoD uses overlapping but distinct elements to bind E-box and tetraplex structures of regulatory sequences of muscle-specific genes.

Authors:  Jeny Shklover; Shulamit Etzioni; Pnina Weisman-Shomer; Anat Yafe; Eyal Bengal; Michael Fry
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.